Endocytosis of tissue-type plasminogen activator (t-PA) by different types of rat liver cells was studied in immunocytochemically labelled cryosections as well as in biochemical experiments. For morphological localization of the ligand in different endocytic compartments involved in its catabolism, rat livers were fixed at various times (1-24 min) after injection of t-PA. Late-endosomal and lysosomal compartments were identified by double-labelling the sections with antibodies to the lysosomal proteins glycoprotein Igp 120 and cathepsin D. In liver t-PA was localized in sinusoidal endothelial cells (EC), parenchymal cells (PC) and to some extent in Kupffer cells (KC), indicating that it is internalized and degraded in all three cell types. In specimens fixed 6 min after injection, PC, EC and KC were found to contribute to 69, 24 and 7 % respectively of total t-PA endocytosed. The transfer from late endosomes to lysosomes was found to be faster in EC than in PC. The morphological findings were supported by studies of the endocytic mechanisms employing isolated perfused livers and primary hepatocytes. The presence of monensin, an inhibitor of lysosomal protein degradation, reduced the amount of t-PA degraded to about 50 % of the control values. The catalytic site seems not to be required for the catabolism of t-PA in hepatic cells. The inhibition of t-PA by D-phenylalanyl-L-prolylarginylchloromethane did not influence receptor recognition and catabolic processing, as determined in morphological studies using labelled cryosections, in binding studies employing liver cell membranes and primary hepatocytes, as well as in liverperfusion experiments.
INTRODUCTION
Tissue-type plasminogen activator (t-PA) is an important component of the fibrinolytic system. It is a glycoprotein with an Mr of approx. 67 000 and is synthesized and secreted by vascular endothelial cells (EC). The serine proteinase t-PA activates the proenzyme plasminogen to plasmin, which subsequently serves to dissolve the fibrin network of a thrombus (Collen et al., 1989) . Owing to the specific binding of t-PA to fibrin and the stimulating effect of fibrin on its plasminogenolytic activity, the activation of plasminogen occurs selectively on the clot surface (Krause & Deutsch, 1989) . Therefore t-PA is employed as a highly effective drug in clinical treatment of thromboembolic disorders (Collen et al., 1989) . t-PA exhibits a short plasma half-life and is rapidly eliminated from the circulation by hepatic uptake (Krause, 1988 ).
An increasing body of evidence indicates that receptormediated endocytosis by liver EC and parenchymal cells (PC) is the primary route of hepatic t-PA degradation (Krause, 1988; Kuiper et al., 1988; Rijken et al., 1990; Smedsr0d & Einarsson, 1990) . Parenchymal liver cells express receptors that mediate the endocytosis of many different ligands [reviewed by Burwen & Jones (1990) ]. The processing of the internalized ligands is determined by the receptor involved and can be divided into three different groups: (i) transcytosis, as for IgA (Hoppe et al., 1985) ; (ii) retroendocytosis, as for transferrin (Stoorvogel et al., 1989; Woods et al., 1989) ; and (iii) lysosomal degradation, as for asialoglycoproteins (Geuze et al., 1983 (Geuze et al., , 1984 (Geuze et al., , 1988 .
Recently it has become evident that liver EC also play a crucial role in the endocytosis of macromolecules present in plasma [reviewed by De Leeuw et al. (1989 ) and Smedsr0d et al. (1990) ]. These cells create a barrier between the lumen of the liver sinusoid and PC. Fenestrated areas in EC make this barrier penetrable for macromolecules, allowing them to enter the space of Disse and reach PC Wisse, 1970 Wisse, , 1972 Wisse, , 1977 . EC were shown to have a number of specific receptors (De Leeuw et al., 1989 and to exhibit a very rapid endocytosis (Magnusson & Berg, 1989) . To identify the different hepatic cell types degrading t-PA and to characterize the catabolic mechanisms involved, we performed morphological as well as biochemical studies. For the immunocytochemical characterization of cellular uptake and intracellular processing of the ligand, we employed labelled cryosections from rat livers fixed at different time points after injection of t-PA. The biochemical data were derived from liver-perfusion experiments and studies using isolated primary hepatocytes and liver cell membranes. and L) Nordic Immunology, Tilburg, Netherlands. Protein A-gold [5 nm (PAG 5) and 10 nm (PAG 10) diameter particles] were prepared as described by (Mohler et al., 1986) . At 1, 6, 12 and 24 min after ligand injection the livers were fixed by perfusion with 0.1 % glutaraldehyde and 4.0 % paraformaldehyde in 0.1 Mphosphate buffer, pH 7.4. Thin liver slices were post-fixed by an additional immersion in the same solution for 1 h and further processed for cryoimmunocytochemistry mainly as described by Tokuyasu (1985) . Cryosections were cut at -95°C on a Sorvall MT 5000 with a FS 1000 cryoattachment using tungsten coated glass knives (Stang, 1988; Stang & Johansen, 1988) . The sections were transferred to glow-discharged (Namork & Johansen, 1982) Formvar-carbon coated grids and further processed for immunocytochemical labelling by the method of Griffiths et al. (1983) . Double labelling was performed as described by Geuze et al. (1983) . The sections were examined in a JEOL 100 CX transmission electron microscope at 80 kV. Serum containing swine anti-rabbit antibodies was used to intensify the labelling of the primary rabbit antibodies (Geuze etal., 1987 (Blouin et al., 1977) , the contribution from each cell type was calculated. The total amount oft-PA associated with the different cell types was calculated by including the number of gold particles found in association with the cell surfaces.
Biochemical experiments
Iodination of t-PA. Recombinant t-PA was labelled to high specific radioactivity by the lodogen method (Fraker & Speck, 1978) using Na'251. The reaction mixture consisted of 2 mCi of Na'251 (50 #1), 8 ,ug of Iodogen and 100 ,1 of t-PA (1 mg/ml).
After the mixture had been shaken for 20 min at room temperature, 400 ,1 of 50 mM-sodium phosphate buffer were added and the labelled protein was isolated on a Sephadex G-25 column. This iodination procedure resulted in specific radioactivities over the range of 2-4 Ci//tg of t-PA.
Perfusion of isolated rat livers. Male rats (Chbb: THOM, (Mohler et al., 1986) . After completion of the perfusion experiments, the livers were weighed and the perfusate samples stored frozen at -20°C until analysis of t-PA antigen levels using an e.l.i.s.a. (Seifried et at., 1988) . To identify the involvement of the active site of t-PA in its hepatic clearance, the active site was blocked with PPACK (Mohler et at., 1986) (Krause et al., 1990) .
Isolation of hepatocyte plasma membranes. Rat liver plasma membranes were prepared and characterized as described by Krause et al. (1990) The protein concentration was determined as described by Peterson (1977) . Enrichment of the plasma membranes in the final fraction was confirmed by measuring the marker enzymes alkaline phosphatase (Pekarthy et al., 1972) (homogenate, 33 munits/mg of protein; final pellet, 1.08 units/mg of protein) and 5'-nucleotidase (Arkesteiji, 1976) ? l l l l -1 l i a i 2 ; . . * , : . . . . . Cell-associated radioactivity in the final pellets was determined in a y-counter, and the protein from the combined supernatants was precipitated at 4°C by addition of trichloroacetic acid Cl3Ac
(final concn. 10 %). Cl3Ac-soluble and -precipitable materials were counted for radioactivity separately. Inhibition of '25l-t-PA endocytosis. Hepatocytes diluted to 4 x 106 cells/ml in Williams E Medium (containing 1 % BSA, 0.1 0% D-glucose and 4,tg/ml each of the proteinase inhibitors chymostatin and leupeptin) were incubated with 'l25-t-PA to a final concentration of 0.25 nm for 2 h at 4 'C. Ligand binding was terminated, and unbound ligand was removed by a 3 min centrifugation at 200 g. The resulting cell pellet was resuspended in an equal volume of prewarmed supplemented Williams E Medium and immediately transferred to 37 'C to allow endocytosis.
For inhibition experiments monensin was included in the binding mixture during the last 30 min of a 2 h incubation at a concentration of 10 or 25 /LM and added again after aspiration of the unbound ligand from the cell pellet. At various intervals, triplicate samples (250 ,ul each) were taken and immediately centrifuged for 2 min at 300 g. The cell pellets were washed once in ice-cold Krebs-Henseleit buffer and the combined supernatants were Cl3Ac-precipitated and radioactivity was determined in a y-radiation counter. C13Ac-soluble material represented radioligand degradation products, whereas Cl3Ac-precipitable contents resembled unbound ligand.
Radioactivity associated with the pellet fraction represented internalized and cell-surface associated radioligand.
Pharmacokinetic data analysis. Individual concentration-time profiles of free t-PA in liver perfusate in the absence or presence of monensin and when inhibited by PPACK were fitted to a twocompartment model via non-linear regression using the program TOPFIT (Heinzel, 1982) . The following pharmacokinetic parameters were calculated using standard formulae (Gibaldi, 1989) : total perfusate clearance, perfusate half-lives and their fractional areas under the curve were expressed per g of liver.
RESULTS

Electron-microscopy studies
The electron-microscopy studies, employing immunocyto- (Fig. la) . After 6 min t-PA was concentrated in cisternal-shaped endosomes which seemed to have increased in volume by that time. Parts of these endosomes had high electron density. In many specimens the ultrastructure of these endosomes indicated a vesicular shape with electron-dense material concentrated at one pole, but thin, well conserved, sections revealed a compartment of cisternal structure, the most electron-dense part representing a dilation of the cisterna (Figs. lb-lc) . In the cisternal or tubular part of the compartment, labelling occurred along the membrane, whereas in the dilated part it was also found in the lumen. In the membrane of the dilated or vesicular part of the endosomes no labelling for the lysosomal glycoprotein Igp 120 was found, but sometimes small amounts were localized on the tubular or cisternal part ofthe compartment (Fig. 1 c) . In specimens prepared 6 min after injection, electron-dense vesicles labelling for t-PA could be seen in addition to the compartments already described. These electron-dense vesicles (Fig. ld-le The labelling pattern of sections prepared 24 min after start of the experiment was identical with the 12 min results, except for an increase in the labelling intensity in the latest compartment.
Endocytosis of t-PA by PC. Specimens fixed 1 min after injection of t-PA exhibited labelling along the plasma membrane, in coated pits, coated vesicles and endosomes with a tubulo/ vesicular or cisternal ultrastructure which were located near the plasma membrane (Figs. 2a and 2b) . At 6 min after injection the concentration of ligand in these peripheral endosomes had increased (Fig. 2c) . In addition to being found in this compartment, t-PA was also found in multivesicular bodies (mvb) (Fig. 2d) , usually appearing in the Golgi region close to the bile canaliculus of the cells. The mvb showed variable ultrastructure: most mvb appeared as vacuoles containing small internal vesicles (Figs. 2d and 3a) , but several mvb showed a more cup-shaped ultrastructure (Fig. 3b) (Fig. 3c) (Wisse, 1974) (Fig. 6) Quantification of endocytosed t-PA. The contribution of each cell type to the endocytosis of t-PA was estimated by counting gold particles found in endocytic compartments of the different cell types on sections from the 6 min specimens. The results of the counting are shown in Tables 1 and 2 . With regard to total cell volume, it was found that PC, EC and KC respectively account for 69, 24 and 7 % of total hepatic endocytosis of t-PA. By incorporating the number of gold particles found at the cell surfaces we found that 80 % were associated with PC and 15.7 % and 4.5 % with EC and KC respectively.
Biochemical studies
The results of the biochemical experiments confirmed the findings of the morphological studies. The experiments were designed to elucidate the involvement of the active site in the recognition of t-PA by its hepatic receptor(s) and to determine whether its degradation involves receptor-mediated endocytosis followed by lysosomal degradation in hepatic cells.
Binding and degradation of inactivated t-PA. In binding experiments employing hepatocytes or hepatocyte plasma membranes, unlabelled t-PA, whether inhibited by PPACK or not, was equally potent in competition for binding of '25I-t-PA (Figs. 8a  and 8b ). That the catalytic site of t-PA is not required for its degradation in either of the liver cell types was suggested by the results of an isolated-rat-liver-perfusion model. The clearance of free and inhibited t-PA from the perfusate was rapid (Fig. 9) , and the pharmacokinetic parameters were not significantly altered after inhibition of its active site by PPACK (Table 3) . inhibitor of several steps involved in the endocytosis and intracellular processing of ligands degraded in liver cells, further supported the results derived from electron-microscopy experiments. Monensin is an ionophore inhibiting receptor recycling and the fusion of endosomes with lysosomes. Employing isolated hepatocytes we investigated the influence of monensin on the binding and internalization, as well as the intracellular degradation, of 1251-t-PA at three different concentrations (12.5, 25 and 50 /tM). In controls the cell-associated portion of t-PA representing surface-bound and internalized ligand decreased from 6.9 fmol/ 106 cells at the start of the experiment to 4.7 fmol/ 106 cells after 5 h. The presence of monensin did not significantly change the amount of cell-associated t-PA (Fig.  lOa) . The fraction of free ligand remained constant at 14.4 fmol/106 cells in the control samples, whereas in the supernatants of the monensin-treated cells it reached a maximum after 1 h that was 20% higher than the control values (Fig. lOb) . The intracellular degradation of t-PA in controls increased from 3.0 fmol/106 cells to 7.6 fmol/106 after 5 h. This process was inhibited by monensin to a maximum of 50% after 90 min (Fig.   lOc) .
Since isolated hepatocytes almost exclusively represent PC, we also investigated the effect of monensin in isolated perfused rat liver. The entire organ contains all the different liver cell types in their physiological arrangement, thus also including EC and KC. In liver-perfusion experiments the addition of monensin resulted in a pronounced inhibition of the uptake of t-PA from the perfusate (Fig. 11) . Accordingly, when expressed in ml/min per g of liver weight (mean + S.D.) the clearance values of 0.339 + 0.064 in the control perfusions were reduced by monensin dose dependently to 0.298 + 0.037 (12.5 ,uM-monensin), 0.1 17+0.014 (25 /uM-monensin) and 0.096+0.020 (50 /tMmonensin). This observation can be explained by the fact that EC are more susceptible to the inhibitory effects of monensin than are PC (Eskild & Berg, 1988) .
DISCUSSION
t-PA has a very short half-life in vivo in the circulation and is eliminated almost exclusively via receptor-mediated endocytosis in the liver (Krause, 1988) . The present study provides morphological as well as biochemical evidence that uptake accounts for clearance of t-PA from the circulation and leads to degradation in PC, EC and KC. The internalization of t-PA in liver cells was not dependent on the active site of the enzyme, since PPACK did not affect binding, uptake or degradation of t-PA at all time points investigated. In electron micrographs of specimens prepared after injection of the t-PA-PPACK complex, labelling was observed in identical compartments, and to the same extent, as in the controls. Receptor recycling as well as endosomal acidification and endosome-lysosome fusion are inhibited by monensin (Berg et al., 1983) . The amount of t-PA degraded in isolated PC in the presence of monensin decreased substantially over time, whereas the concentration of free ligand in the medium increased compared with controls. The latter finding, together with the observation that the amount of t-PA associated with the cells did not change over time, proves that, in the presence of monensin, no receptor recycling from a latent intracellular pool occurs. In the isolated-liver-perfusion model the effect of monensin was much more pronounced than in experiments using isolated PC in the presence of monensin decreased substantially than PC (Eskild & Berg, 1988) , this result confirms the substantial involvement of hepatic EC in the degradation of t-PA.
The binding of t-PA to EC has been shown to depend on the presence of mannose structures in the molecule (Smedsr0d et al., 1988; Smedsr0d & Einarsson, 1990) and, accordingly, removal of these carbohydrates resulted in reduced hepatic clearance of this t-PA variant (Tanswell et al., 1989; Seydel et al., 1991) . In a previous study we showed that t-PA bound almost exclusively in coated pits in EC (Stang et al., 1991a) . In PC, t-PA appeared in coated and uncoated membrane segments. The different receptor localization in membranes of EC and PC could be one explanation for the biphasic clearance pattern observed for t-PA.
The uptake of t-PA in PC has been reported to be mediated both by a galactose receptor and a specific t-PA receptor [reviewed by Rijken et al. (1990) ]. The results of our immunocytochemicallabelling experiments prove that t-PA is endocytosed and intracellularly processed in PC. The endocytosed t-PA is mainly routed to the lysosomes. Minor labelling in the bile canaliculi indicates that some t-PA follows the transcytotic pathway, probably as result of miss-sorting in early endosomes (Limet et al., 1985) . The-endocytosed t-PA seems to follow the same route as asialoglycoproteins endocytosed by the galactose receptor of PC (Geuze et al., 1983 (Geuze et al., , 1984 (Geuze et al., , 1988 structure. Geuze et al. (1983) described this compartment as tubulovesicular and named it 'CURL' (Compartment of Uncoupling of Receptor and Ligand). This compartment most likely represents the early endosomes of the PC. Our results show that the 'vesicular part' of this compartment contains an inner membrane (Figs. 2b-2d ), indicating that it probably is part of a cisternal-shaped structure, as has been shown to be the case for early endosomes in other cell types (McDowall et al., 1989) . From the early endosome the ligand is transferred to multivesicular bodies (mvb). The structure of the mvb varies and in some micrographs the compartment appears to consist of a network of intertwined tubular structures rather than being a vacuole which contains vesicles (see Fig. 5 ). Griffiths et al. (1988 Griffiths et al. ( , 1990 described late endosomal or prelysosomal compartments as complex structures of tubuloreticular domains aligned with vesicular parts containing internal membrane structures organized in tubules or sheets. The t-PA and Igp 120 positive organelles in our study are very similar to the mvb described by Geuze et al. (1984) and most likely represent late endosomes or prelysosomes. Vesicles labelling for t-PA at a later time point (24 min after injection) were immunocytochemically characterized as lysosomes using antibodies against Igp 120 and cat D Kornfeld & Mellman, 1989) . The content of ferritin-like particles in these structures (Fig. 4 ) also identifies these vesicles as lysosomes (Geuze et al., 1984) . The appearance of t-PA in late endosomes rules out transcytosis as a major catabolic pathway. Transcytosed ligands do not appear in mvb or lysosomes unless miss-sorted (Hoppe et al., 1985) , but instead are shuttled directly to the bile canaliculi in vesicles budding off early endosomes. The localization of t-PA in possible autophagic vacuoles indicates that the autophagic and endocytic pathway meet. Tooze et al. (1990) recently showed that, in exocrine pancreas, these pathways converge immediately after the early endosomal step. E. Stang and others t-PA endocytosed by EC also appears to be degraded intracellularly without being transcytosed (Stang et al., 1991a) . The intracellular processing of the ligand is similar to that of ovalbumin (OVA) Stang et al., 1990) . OVA is a glycoprotein that is endocytosed by the mannose receptor in EC (Magnusson & Berg, 1988) . The cisternal-shaped compartments labelling for t-PA after as short a time as 1 min are likely to represent early endosomes. The difference observed in studies employing either OVA or t-PA is the high electron density of the dilated or vesicular part of early endosomes containing t-PA. OVA was localized in cisternal and tubulovesicular early endosomes which ultrastructurally were identical with structures containing t-PA, except for their electron-dense contents. However, recent results from co-injection of equal doses of OVA and t-PA in rats show that the two ligands are localized in the same early endosomes in EC (Stang et al., 199 lb) . Why early endosomes containing t-PA appear electron-dense in EC is unclear. The proteolytic activity of t-PA cannot account for this phenomenon, because t-PA inactivated by PPACK was found in endosomal structures identical with those containing active t-PA.
Both the volume-of the early endosomes and the labelling intensity for t-PA seems to increase from the 1 min to the 6 min specimens, which indicates constant fusion of vesicles containing t-PA with the organelle. After enrichment in early endosomes the ligand is possibly transferred to late endosomes by large carrier vesicles pinching off the dilated part of the endosome . The large electron-dense vesicles observed in specimens prepared 6 min after the injection of t-PA may represent such carrier vesicles. These vesicles differ from the dilated part ofearly endosomes by labelling for Igp 120. However, because Gruenberg et al. (1989) did not mention Igp 120 in their work on carrier vesicles, and since larger amounts of Igp 120 are only found in late endosomes and lysosomes Kornfeld & Mellman, 1989) , we decided to name the electron-dense vesicles containing Igp 120 'late endosomes'.
Lysosomes of EC are probably the large electron-lucent vesicles containing t-PA, Igp 120 and cat D (Fig. lf) which are observed in specimens prepared 12 min after injection of the ligand (Stang et al., 1991a) . In a previous study on OVA we found small amounts of cat D to be associated with electron-dense vesicles ), which we then, in accordance with previous reports on dense bodies in EC (De Bruyn et al., 1983) , described as lysosomes. The results of the present investigation, however, suggest that these dense structures are late endosomes rather than lysosomes. Preliminary results obtained from 'loading' lysosomes in EC by injection of colloidal gold coated with mannosylated albumin 24 h before fixation support the notion that lysosomes are the large vesicular compartments with a rather electron-lucent content. However, the existence of a heterogeneous lysosome population in EC cannot be excluded. It has recently been shown that mannosylated albumin may be degraded sequentially in two types of lysosomes . A similar two-step lysosomal processing has been found in macrophages (Tassin et al., 1990) .
Endocytosis in KC was not studied in detail, owing to insufficient ultrastructural preservation, but we have shown previously that this cell type may internalize large amounts of t-PA (Stang et al., 1991a) . In KC 1 min after injection, t-PA was found in coated pits and coated vesicles, in large vacuoles as well as in so-called 'worm-like' structures. This indicates uptake by specific receptor-mediated endocytosis as well as macropinocytosis or phagocytosis (Wisse, 1974 (Wisse, , 1977 . At later time points t-PA is found in several intracellular compartments, including large vesicles labelling for both cat D and Igp 120, suggesting a final degradation in lysosomes (Stang et al., 1991a) .
The quantitative studies indicate that the uptake in PC is three times that of EC. However, these calculations must, for several reasons, be considered semi-quantitative. After thawing the sections there is no resin to keep the EC in position during the labelling procedure. In ultra-thin sections this results in dislocation and also loss of parts of EC . In an attempt to avoid this problem, quantification was done on sections with a nominal thickness of 150 nm. However, parts of the EC were still lost. The increased section thickness may lead to reduced labelling sensitivity in some compartments, such as coated pits and coated vesicles, and the labelling intensity of larger compartments may not only depend on the amount of t-PA but also the degree of penetration into the compartment (Griffiths & Hoppeler, 1986) . The quantification is also influenced by the location in the sinusoid from which the sections are taken. By using t-PA labelled with the fluorophore 5-[4,6-dichlorotriazin-2-yl)amino]fluorescein, a gradient of uptake can be seen within the liver lobules (H. Deutsch & J. Krause, unpublished work). For several ligands endocytosed by PC a lobular concentration gradient exists: PC located near the portal veins endocytose higher amounts than PC located near the central veins (Burwen & Jones, 1990 ). KC are not distributed homogeneously along the sinusoid: the majority of KC are located around the portal veins, where the cells are larger and more active than those located near the central vein (Wake et al., 1989) . The small specimens used for cryo-sectioning clearly interfere with the quantification. Kuiper et al. (1988) reported that 54.5, 39.5 and 6% of t-PA were in PC, EC and KC respectively, and the corresponding results reported by Smedsr0d & Einarsson (1990) were 45, 44 and 11 % for the same cells. This suggests that the uptake in PC might be overestimated. This may be explained by different kinetics in intracellular processing of internalized ligands in the different cell types. In EC, t-PA was found in lysosomes 12 min after injection, whereas in PC no labelling was observed in lysosomes until 24 min after injection. This indicates that intracellular processing is faster in EC than in PC. On the other hand, the total surface population of (at least) galactose receptors on PC is much higher than the total surface population of mannose receptors on EC (Magnusson & Berg, 1989) . At the relatively early time point at which the quantification was performed (6 min after injection), the PC might show a high concentration of endocytosed t-PA, owing to the high number of available receptors on the surface, whereas EC show a relatively low concentration of t-PA, owing to a considerably lower number of receptors on the surface. Over a longer period of time, however, the originally minor contribution by EC might be compensated for by a fast recycling of receptors in EC compared with PC. Magnusson et al. (1991) recently found retroendocytosis to occur about four times faster in EC than in PC, indicating that recycling of receptors is very rapid in EC. An additional indication that a longer period of time is needed to determine the total contribution of EC is the observation that the effect of monensin in the isolated liver perfusion model is first seen after 15 min. A quantification at this time point might, however, be disturbed by degradation and reduced antigenicity of the ligand in EC.
In addition to endocytosed t-PA, we also calculated cellassociated t-PA, demonstrating an even larger contribution of PC. The biochemically determined calculations reported by Kuiper et al. (1988) and Smedsr0d & Einarsson (1990) take into account endocytosed t-PA and cannot be compared with the present quantification of cell-associated t-PA. However, the difference we observed between estimations for endocytosed and cell-associated t-PA can be partly explained by the observation that PC bind t-PA in both coated and uncoated parts of the membrane, whereas EC only bind t-PA in coated pits, which, in the sections used for quantification, are often not available for labelling. The difference may also be explained by the very short half-life observed for the ligand-receptor complex in EC compared with other cell types (Magnusson & Berg, 1989) .
